有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | (3S)-1-methyl-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]pyrrolidin-2-one | —— | C8H11N3OS2 |
|
—— | (3S)-1-methyl-3-[[5-(2-methylfuran-3-yl)-4-prop-2-enyl-1,2,4-triazol-3-yl]sulfanyl]pyrrolidin-2-one | —— | C15H18N4O2S |
|
—— | (3R)-3-[[4-benzyl-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]-1-methylpyrrolidin-2-one | —— | C19H20N4O2S |
|
—— | (3R)-1-methyl-3-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]pyrrolidin-2-one | —— | C9H12N2OS2 |
|
—— | (3S)-1-methyl-3-[(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)sulfanyl]pyrrolidin-2-one | —— | C11H11N3O2S2 |
|
—— | (3S)-3-[[4-amino-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]-1-methylpyrrolidin-2-one | —— | C12H15N5O2S |
|
—— | (3R)-1-methyl-3-[[4-methyl-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]pyrrolidin-2-one | —— | C13H16N4O2S |
|
—— | (3S)-3-[[4-benzyl-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]-1-methylpyrrolidin-2-one | —— | C19H20N4O2S |
|
—— | (3R)-1-methyl-3-[[5-[(2R)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]pyrrolidin-2-one | —— | C16H19N3O2S |
|
—— | (3R)-1-methyl-3-[(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)sulfanyl]pyrrolidin-2-one | —— | C11H11N3O2S2 |
|
—— | (3R)-1-methyl-3-pyridin-2-ylsulfanylpyrrolidin-2-one | —— | C10H12N2OS |
|
—— | (3S)-1-methyl-3-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]pyrrolidin-2-one | —— | C14H16N4OS2 |
|
—— | (3S)-1-methyl-3-(1-methylimidazol-2-yl)sulfanylpyrrolidin-2-one | —— | C9H13N3OS |
|
—— | (3R)-1-methyl-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]pyrrolidin-2-one | —— | C8H11N3OS2 |
|
—— | (3S)-1-methyl-3-[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanyl]pyrrolidin-2-one | —— | C13H13N3O2S |
|
—— | (3S)-3-[[5-(2,3-dimethylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-1-methylpyrrolidin-2-one | —— | C15H18N4OS2 |
|
—— | (3R)-1-methyl-3-[(5-methyl-4-prop-2-enyl-1,2,4-triazol-3-yl)sulfanyl]pyrrolidin-2-one | —— | C11H16N4OS |
|
—— | (3R)-1-methyl-3-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]pyrrolidin-2-one | —— | C14H16N4OS2 |
|
—— | (3R)-1-methyl-3-(1-methyltetrazol-5-yl)sulfanylpyrrolidin-2-one | —— | C7H11N5OS |
|
—— | (3R)-1-methyl-3-[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanyl]pyrrolidin-2-one | —— | C13H13N3O2S |
|
—— | 3-[(1S)-1-ethoxyethyl]-5-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole | —— | C14H17N5O2S2 |
|
—— | 3-[(1R)-1-ethoxyethyl]-5-[[1-(2,2,2-trifluoroethyl)tetrazol-5-yl]sulfanylmethyl]-1,2,4-oxadiazole | —— | C10H13F3N6O2S |
|
—— | (3R)-3-[[5-(3,4-dimethylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-1-methylpyrrolidin-2-one | —— | C15H18N4OS2 |
|
—— | 3-[(1R)-1-ethoxyethyl]-5-[(4-methyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanylmethyl]-1,2,4-oxadiazole | —— | C14H17N5O2S2 |
|
—— | 3-[(1R)-1-ethoxyethyl]-5-(1,3,4-thiadiazol-2-ylsulfanylmethyl)-1,2,4-oxadiazole | —— | C9H12N4O2S2 |
|
—— | (3S)-3-[[5-(3,4-dimethylanilino)-1,3,4-thiadiazol-2-yl]sulfanyl]-1-methylpyrrolidin-2-one | —— | C15H18N4OS2 |
|
—— | (3S)-1-methyl-3-pyridin-2-ylsulfanylpyrrolidin-2-one | —— | C10H12N2OS |
|
—— | 5-[(1-cyclopropyltetrazol-5-yl)sulfanylmethyl]-3-[(1S)-1-ethoxyethyl]-1,2,4-oxadiazole | —— | C11H16N6O2S |
|
—— | 3-[(1R)-1-ethoxyethyl]-5-[(1-methylimidazol-2-yl)sulfanylmethyl]-1,2,4-oxadiazole | —— | C11H16N4O2S |
|
—— | (3R)-1-methyl-3-(1-methylimidazol-2-yl)sulfanylpyrrolidin-2-one | —— | C9H13N3OS |
|
—— | 2-[(3S)-2-oxooxolan-3-yl]sulfanylpyridine-4-carbonitrile | —— | C10H8N2O2S |
|
—— | 3-[(1S)-1-ethoxyethyl]-5-(1,3,4-thiadiazol-2-ylsulfanylmethyl)-1,2,4-oxadiazole | —— | C9H12N4O2S2 |
|
—— | 3-[(1S)-1-ethoxyethyl]-5-[(1-methylimidazol-2-yl)sulfanylmethyl]-1,2,4-oxadiazole | —— | C11H16N4O2S |
|
—— | 2-(4-cyanopyridin-2-yl)sulfanyl-N-[(R)-cyclopropyl-(4-methylphenyl)methyl]acetamide | —— | C19H19N3OS |
|
—— | 2-(4-cyanopyridin-2-yl)sulfanyl-N-[(1R)-1-(furan-2-yl)ethyl]acetamide | —— | C14H13N3O2S |
|
—— | 3-[(1S)-1-ethoxyethyl]-5-[[1-(2,2,2-trifluoroethyl)tetrazol-5-yl]sulfanylmethyl]-1,2,4-oxadiazole | —— | C10H13F3N6O2S |
|
—— | 5-[(1-cyclopropyltetrazol-5-yl)sulfanylmethyl]-3-[(1R)-1-ethoxyethyl]-1,2,4-oxadiazole | —— | C11H16N6O2S |
|
—— | 5-[(1-cyclopentyltetrazol-5-yl)sulfanylmethyl]-3-[(1R)-1-ethoxyethyl]-1,2,4-oxadiazole | —— | C13H20N6O2S |
|
—— | 2-(4-cyanopyridin-2-yl)sulfanyl-N-(2-phenylethyl)acetamide | —— | C16H15N3OS |
|
—— | 5-[(1-cyclopentyltetrazol-5-yl)sulfanylmethyl]-3-[(1S)-1-ethoxyethyl]-1,2,4-oxadiazole | —— | C13H20N6O2S |
|
—— | 2-[(3R)-2-oxooxolan-3-yl]sulfanylpyridine-4-carbonitrile | —— | C10H8N2O2S |
|
—— | (2R)-N-cyclohexyl-N,3-dimethyl-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]butanamide | —— | C15H25N3OS2 |
|
—— | 2-(4-cyanopyridin-2-yl)sulfanyl-N-[(S)-cyclopropyl-(4-methylphenyl)methyl]acetamide | —— | C19H19N3OS |
|
—— | 2-(4-cyanopyridin-2-yl)sulfanyl-N-[(1S)-1-(furan-2-yl)ethyl]acetamide | —— | C14H13N3O2S |
|
—— | (2S)-N-cyclohexyl-N,3-dimethyl-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]butanamide | —— | C15H25N3OS2 |
|
—— | 3-Cyclopropyl-5-[(2-methylphenyl)methylsulfanyl]-1,2,4-triazol-4-amine | —— | C13H16N4S |
|
—— | (3S)-N'-[3-(4,6-dimethyl-2-methylsulfanylpyrimidin-5-yl)propanoyl]-1,1-dioxothiolane-3-carbohydrazide | —— | C15H22N4O4S2 |
|
—— | 3-Cyclopropyl-5-[(2,5-dimethylphenyl)methylsulfanyl]-1,2,4-triazol-4-amine | —— | C14H18N4S |
|
—— | 3-Cyclopropyl-5-[[2-(4-methylphenyl)-1,3-thiazol-4-yl]methylsulfanyl]-1,2,4-triazol-4-amine | —— | C16H17N5S2 |
|
—— | 4-[(4-amino-5-cyclopropyl-1,2,4-triazol-3-yl)sulfanylmethyl]-N-(4-methylphenyl)-1,3-thiazol-2-amine | —— | C16H18N6S2 |
|